R
RPRX
Royalty Pharma Plc
53.97
+0.11+0.20%After Hours: 53.97 0.00 0.00%16:19 05/27 EDT
OPEN/PREV CLOSE53.84/53.86
TODAY RANGE53.50-54.68
VOL3.08M
MARKET CAP31.08B
52 WEEK RANGE31.53-54.74
AVG VOL (3M)3.34M
% TURNOVER0.53%
TURNOVER--
P/E (TTM)28.27
% RANGE2.19%
EPS(TTM)1.909
P/E(FORWARD)17.47
P/B4.514
BVPS11.96
DIVIDEND0.9400
P/S13.10
BETA--
DIV YIELD1.74%
FREE FLOAT MKT CAP22.21B
SHARES OUTSTANDING575.83M
NEXT EARNINGS08/04-08/10
FREE FLOAT411.47M
LOT SIZE1
EX-DATE05/15/2026
News
Press Releases
Financial Reports
Profile
Seeking Alpha·05/16 07:12
Royalty Pharma: Strong Execution, Expanding Pipeline And More Firepower Ahead
Simply Wall St·05/14 12:34
Royalty Pharma (RPRX) Valuation Check After Strong Q1 Earnings And Rising Investor Interest
Simply Wall St·05/10 16:21
Accelerated Royalty Deals and Dividend Hike Could Be A Game Changer For Royalty Pharma (RPRX)
Dow Jones·05/07 21:04
Royalty Pharma Price Target Raised to $66.00/Share From $50.00 by Citigroup
Dow Jones·05/07 21:04
Royalty Pharma Is Maintained at Buy by Citigroup
Benzinga·05/07 20:54
Citigroup Maintains Buy on Royalty Pharma, Raises Price Target to $66
Dow Jones·05/07 19:53
Royalty Pharma Is Maintained at Overweight by JP Morgan
Dow Jones·05/07 19:53
Royalty Pharma Price Target Raised to $58.00/Share From $50.00 by JP Morgan
Benzinga·05/07 19:44
JP Morgan Maintains Overweight on Royalty Pharma, Raises Price Target to $58
TipRanks·05/07 19:05
Royalty Pharma price target raised to $64 from $63 at Morgan Stanley
Same Industry
Name/Symbol
Change%
Price